Tissue Heart Valve Market Report 2024 (Global Edition)

Global Tissue Heart Valve Market Report 2024 Market Size Split by Type (Natural Material, Synthetic Material), by Application (Heart Surgery, Cardiovascular Disease), by Procedure (Surgical Heart Valv...

Tissue Heart Valve Market Report Description

We have various report editions of Tissue Heart Valve Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Tissue Heart Valve Market Insights Video

Competitive Landscape of the Tissue Heart Valve Market

A number of major competitors in the tissue heart valve industry are constantly innovating, forming strategic alliances, and expanding their businesses in an effort to hold onto market share.

March 2023: Abbott declared that its EpicTM Max stented tissue valve, intended to treat patients with aortic regurgitation or stenosis, has received FDA approval. With an enhanced design to further increase valve blood flow, this device is the newest addition to Abbott's Epic surgical valve platform, which has a long history of safety and positive clinical outcomes. Source: https://abbott.mediaroom.com/2023-03-30-Abbott-Receives-FDA-Approval-for-Epic-TM-Max-Tissue-Valve-to-Treat-Aortic-Valve-Disease.

 

Top Companies Market Share in Tissue Heart Valve Industry: (In no particular order of Rank)

• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• JenaValve Technology
• Inc.
• Artivion
• Inc.
• Meril Life Sciences Pvt. Ltd.
• Abbott Laboratories
• LivaNova PLC
• Medtronic plc
• ShockWave Medical
• Inc.
• Labcor Laboratorios Ltd
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Tissue Heart Valve Market

Which Region Dominates the Tissue Heart Valve Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It is anticipated that the tissue heart valve market in North America would continue to develop due to favorable healthcare policies, technological improvements, and the rising incidence of heart valve illnesses. The emphasis on less invasive treatments, including TAVR, and continuous advancements in material and valve design will probably boost market expansion even further. Furthermore, the region will continue to promote market expansion due to its strong healthcare infrastructure and emphasis on early identification and treatment of cardiovascular problems.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Tissue Heart Valve market. Rapid population aging in nations like South Korea, China, and Japan has raised the demand for tissue heart valve replacements by increasing the prevalence of heart valve disorders. Moreover, more people are undergoing heart valve replacement surgeries due to investments in healthcare infrastructure and improved access to cutting-edge medical technologies.

 

The current report Scope analyzes Tissue Heart Valve Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Tissue Heart Valve Market

According to Cognitive Market Research, the global Tissue Heart Valve market size was estimated at USD 1624.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 649.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Tissue Heart Valve market with a market size of USD 512.60 million in 2024 and is projected to grow at a CAGR of 10.5% during the forecast period. The demand is amplified by the nation's growing prevalence of CVD.
• The Canada Tissue Heart Valve market had a market share of USD 77.96 million in 2024 and is projected to grow at a CAGR of 11.5% during the forecast period. Canada's rising investment.
• The Mexico Tissue Heart Valve market is projected to witness growth at a CAGR of 11.2% during the forecast period, with a market size of USD 59.12 million in 2024.

Europe Tissue Heart Valve Market

According to Cognitive Market Research, the global Tissue Heart Valve market size was estimated at USD 1624.2 Million out of which Europe held the market more than 30% of the global revenue with a market size of USD 487.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.0% from 2024 to 2031.

• The United Kingdom's Tissue Heart Valve market had a market share of USD 81.86 million in 2024 and is projected to grow at a CAGR of 11.8% during the forecast period. In the UK, Tissue Heart Valve sales witnessed an upswing due to the growing investment.
• The France Tissue Heart Valve market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 44.83 million in 2024.
• According to Cognitive Market Research, the German Tissue Heart Valve market size was valued at USD 96.48 million in 2024 and is projected to grow at a CAGR of 11.2% during the forecast period. In Germany, Tissue Heart Valve sales surged due to the increasing prevalence of CVD.
• The Italy Tissue Heart Valve market is projected to witness growth at a CAGR of 10.4% during the forecast period, with a market size of USD 41.90 million in 2024.
• The Russia Tissue Heart Valve market is projected to witness growth at a CAGR of 10.0% during the forecast period, with a market size of USD 75.53 million in 2024.
• The Spain Tissue Heart Valve market is projected to witness growth at a CAGR of 10.1% during the forecast period with a market size of USD 39.96 million in 2024
• The Luxembourg Tissue Heart Valve market is projected to witness growth at a CAGR of 11.1% during the forecast period, with a market size of USD 15.11 million in 2024.
• The Portugal Tissue Heart Valve market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 10.23 million in 2024.
• The Greece Tissue Heart Valve market is projected to witness growth at a CAGR of 11.3% during the forecast period, with a market size of USD 5.85 million in 2024.
• Rest of Europe's Tissue Heart Valve market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 75.53 million in 2024.

Asia Pacific Tissue Heart Valve Market

According to Cognitive Market Research, the global Tissue Heart Valve market size was estimated at USD 1624.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 373.57 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.5% from 2024 to 2031.

• According to Cognitive Market Research, China's Tissue Heart Valve market size was valued at USD 168.10 million in 2024 and is projected to grow at a CAGR of 14.0% during the forecast period. Tissue Heart Valve sales surged in China due to increasing investment.
• The Japan Tissue Heart Valve market is projected to witness growth at a CAGR of 13.0% during the forecast period, with a market size of USD 51.55 million in 2024.
• The India Tissue Heart Valve market had a market share of USD 44.83 million in 2024 and is projected to grow at a CAGR of 16.3% during the forecast period. India's rising healthcare expenditures.
• The South Korea Tissue Heart Valve market is projected to witness growth at a CAGR of 13.6% during the forecast period, with a market size of USD 37.36 million in 2024.
• The Australian Tissue Heart Valve market is projected to witness growth at a CAGR of 14.2% during the forecast period, with a market size of USD 19.43 million in 2024.
• The South East Asia Tissue Heart Valve market is projected to witness growth at a CAGR of 15.5% during the forecast period, with a market size of USD 25.78 million in 2024.
• The Rest of the Asia Pacific Tissue Heart Valve market is projected to witness growth at a CAGR of 14.3% during the forecast period, with a market size of USD 26.52 million in 2024.

South America Tissue Heart Valve Market

According to Cognitive Market Research, the global Tissue Heart Valve market size was estimated at USD 1624.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 81.21 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.9% from 2024 to 2031

• According to Cognitive Market Research, Brazil's Tissue Heart Valve market size was valued at USD 34.76 million in 2024 and is projected to grow at a CAGR of 12.5% during the forecast period. Tissue Heart Valve sales flourish in Brazil due to rising investment.
• Argentina Tissue Heart Valve market had a market share of USD 13.64 million in 2024 and is projected to grow at a CAGR of 12.8% during the forecast period. The growing investment drives the market growth in the nation.
• Colombia Tissue Heart Valve market is projected to witness growth at a CAGR of 11.7% during the forecast period with a market size of USD 7.23 million in 2024.
• Peru Tissue Heart Valve market is projected to witness growth at a CAGR of 12.1% during the forecast period with a market size of USD 6.66 million in 2024.
• Chile Tissue Heart Valve market is projected to witness growth at a CAGR of 12.2% during the forecast period with a market size of USD 5.85 million in 2024.
• The Rest of Latin America Tissue Heart Valve market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD 13.07 million in 2024.

Middle East and Africa Tissue Heart Valve Market

According to Cognitive Market Research, the global Tissue Heart Valve market size was estimated at USD 1624.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 32.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.2% from 2024 to 2031.

• The GCC Countries Tissue Heart Valve market is projected to witness growth at a CAGR of 13.0% during the forecast period with a market size of USD 13.90 million in 2024. Tissue Heart Valve sales flourish due to the growing technological advancements.
• The Egypt Tissue Heart Valve market is projected to witness growth at a CAGR of 12.5% during the forecast period, with a market size of USD 3.41 million in 2024.
• The South Africa Tissue Heart Valve market is projected to witness growth at a CAGR of 13.2% during the forecast period, with a market size of USD 5.13 million in 2024. Tissue Heart Valve sales flourish in South Africa due to the rising investment.
• The Turkey Tissue Heart Valve market is projected to witness growth at a CAGR of 11.7% during the forecast period, with a market size of USD 2.79 million in 2024.
• The Nigeria Tissue Heart Valve market is projected to witness growth at a CAGR of 11.3% during the forecast period, with a market size of USD 3.41 million in 2024.
• The Rest of MEA Tissue Heart Valve market is projected to witness growth at a CAGR of 11.2% during the forecast period, with a market size of USD 3.83 million in 2024.

Tissue Heart Valve Market Analysis

Tissue Heart Valve Market Type Segment Analysis

According to Cognitive Market Research, Synthetic Material stands out as the dominating category. In comparison to conventional bioprosthetic valves, synthetic materials may be designed to withstand the mechanical strains and wear and tear that occur in the heart. This could result in valves that last longer. These materials can also be made to be less prone to calcification, which is a typical concern with tissue valves and can eventually cause valve dysfunction.

Natural Material emerged as the fastest-growing category in the Tissue Heart Valve market. Compared to synthetic materials, natural materials are often well-tolerated by the body, lowering the possibility of unfavorable immunological reactions. Furthermore, tissue valves composed of natural materials provide better hemodynamics and closely resemble the function of a natural valve, resulting in more naturally occurring pressure gradients and blood flow.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Tissue Heart Valve Industry. Request a Free Sample PDF!

Tissue Heart Valve Market Application Segment Analysis

According to Cognitive Market Research, the dominating category is Heart Surgery. The market for tissue heart valves in cardiac surgery appears to have a bright future due to continual improvements in surgical methods, a rise in the popularity of minimally invasive procedures, and constant innovation in valve technology. Enhancing patient outcomes, broadening market access in emerging nations, addressing the issues of valve degeneration and reoperation, and improving valve durability are important areas of focus. The need for long-lasting and efficient heart valve replacement options, such as tissue heart valves, is anticipated to increase as global healthcare systems continue to change.

The fastest-growing category in the Tissue Heart Valve market is Cardiovascular Disease. The segment expansion is attributed to the rising prevalence of CVD across the globe and ongoing technological advancement in surgery procedure.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Tissue Heart Valve Procedure Segment Analysis

Procedure Segment Analysis

According to Cognitive Market Research, the dominating category is Surgical Heart Valve Replacement. The aging population, rising incidence of heart valve illnesses, and improvements in surgical technologies have created a sizable and expanding global market for surgical heart valve replacements, including tissue heart valves.

The fastest-growing category in the Tissue Heart Valve market is Transcatheter Heart Valve Replacement. Technology breakthroughs, clinical data demonstrating TAVR's safety and effectiveness, and rising physician proficiency with these treatments are all contributing to the procedure's expanding global use. The market dynamics and competitive landscape of TAVR technology are significantly shaped by regulatory approvals for expanding indications and ongoing clinical trials.

• Surgical Heart Valve Replacement
• Transcatheter Heart Valve Replacement

Tissue Heart Valve End User Segment Analysis

End User Segment Analysis

According to Cognitive Market Research, the dominating category is Hospitals. Hospitals use the number of heart valve replacement procedures they undertake to determine the demand for tissue heart valves. Demand has an impact on pricing, procurement tactics, and product preferences, among other market variables. The market for tissue heart valves is heavily impacted by the use of new technology and surgical methods in hospital settings, such as TAVR, as these facilities look for creative ways to save costs and enhance patient outcomes.

The fastest-growing category in the Tissue Heart Valve market is Cardiac Centers. Patients with complicated cardiovascular illnesses, such as heart valve disorders, can get comprehensive care at cardiac centers. They offer a variety of services, including sophisticated surgical procedures like heart valve replacements as well as medical management and diagnosis. Teams of highly skilled cardiologists, cardiac surgeons, anesthesiologists, and other medical specialists that specialize in cardiovascular care work at these centers. Their knowledge guarantees that patients receive customized treatment regimens for their unique heart valve diseases, including the choice of suitable tissue heart valves according to patient preferences and clinical indications. Thereby, driving the market growth.

• Hospitals
• Cardiac Centers
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion